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Currently, 18.2 million adults aged 20 and older are diagnosed with Coronary 
Artery Disease (CAD) (Benjamin et al., 2019).. Stenosis is the most common 
intervention. However, when a patient has a bifurcated artery, treatment becomes more 
difficult and is often unsuccessful. This project created a new stent and balloon complex 
that was tested in vitro using a gel phantom artery model. Two separate prototypes have 
been created and tested so far, with improvements made upon each. Testing is still 



















Coronary artery stenosis is one of the most common issues that cardiologists 
treat. In coronary artery stenosis, an atherosclerotic plaque constricts blood flow. And, in 
the most severe cases, complete blockage of blood flow due to plaque build-up within the 
artery leads to a heart attack. Several advancements have been made in intervention 
efforts. Coronary artery bypass surgery used to be the only treatment option, but for the 
last three decades, coronary stents have revolutionized how physicians treat coronary 
artery disease and heart attacks. A deflated balloon is placed inside the stent, which is 
then inserted into the artery through an incision. Tubing connects the balloon/stent 
complex to a pressure source so that when pressure is applied, the balloon expands and 
the stent deploys. The stent stays in place, and the balloon is removed.  
However, complex areas of stenosis, such as a bifurcation lesion, are more 
difficult to treat. A bifurcated artery is one that is branched, usually with plaque at the 









These lesions account for approximately one-fifth of all coronary stenosis, but 
are a medical issue for which no “perfect” solution currently exists (​Antoniadis et al., 
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2015)​. This project specifically targets bifurcations with a Medina classification 
geometry (1, 0, 0) (Louvard & Medina, 2015). The most common intervention is to 
deploy two separate stents, but this can be technically time-consuming and complicated, 
and the rates of restenosis are high (Aoki, 2006).  Bifurcation vessels are difficult to treat 
because no two vessels are the same. Each has different properties and different amounts 
of blockage, which prevents researchers from finding one true solution. The most 
common method used to treat these vessels is to insert one wire and stent into the main 
branch, and a second wire and stent into the side branch (Sawaya et al., 2016). This 
process is not easy to complete, and these vessels typically have higher rates of restenosis 












III. Initial Proposal 
This project was in collaboration with the University of Utah. There were two main aims 
of this project: to develop a Finite-Element (FE) modeling system in order to predict the outcome 
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of our stent-phantom model, and to create the physical stent-phantom model to test. Researchers 
in Utah were responsible for creating the FE model, and all of our data was shared with them for 
this purpose. The main aim of this project was to simplify the process of repairing bifurcation 
vessels, as well as increasing the success rate of these repairs and decreasing rates of restenosis 
and thrombosis. In addition, the FE component was added so that patient-specific models and 
stents can be created in the future (Jensen & Timmins, 2016).  
IV. Prototype Version 1 (2018) 
The first version of the balloon-stent complex was completed in 2018. The stent itself 
was designed on the SolidWorks engineering software, then produced by manufacturers using an 
oxygen-laser cutter at Hi-Tech Welding in Lee’s Summit, Missouri. The stent was made of 
stainless steel 316L, and was originally cut into a flat dimension before being welded into a 
cylindrical shape. The initial stent balloon was purchased from Nordson Medical and was made 
from Polyethylene Terephthalate (PET), a stiff and clear plastic. PET has a good glass transition 
temperature (exact values are between 73-78 degrees Celsius), which means that the material 
easily melts into a “viscous liquid” that can easily be molded into a new shape, especially with 
blow molding. This property is beneficial in this case because the PET is able to be heated at a 
low temperature, then air blows it into a balloon shape (Polyethylene, n.d.).  
Next, a crimper was used to make the stent as compact as possible. The balloon was then 
inserted into the stent, and then the balloon-stent complex was placed within the phantom. The 
balloon was attached to an inflator using PET tubing, and the inflator was pumped up to 11 atm. 
This was a very crude model. The stents themselves had many issues, mainly that there was a 
large amount of porous residue, or slag, on all surfaces of the stents. Because of this, the welds 
were unable to hold at several different points. In addition, the porous edges were so sharp that 
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they pierced some of the balloons. All of the stents in this first prototype broke during the 
crimping process or while they were being deployed.  
V. Prototype Version 2 (2019) 
After the first round of stents was created, we tried to make optimal changes in order to 
reduce the number of breaks that were occuring. First, a change was made in the laser-cutting 
technique of the steel pieces. The second group of stents were cut using a nitrogen laser, rather 
than one that uses oxygen. The oxygen laser had caused an oxidation reaction with the steel, 
which was forming the slag on the stents (Wiley, 2017). A benefit to the oxygen laser was that it 
cut somewhat quicker than the nitrogen, and it was also cheaper. Second, we employed a tactic 
called passivation in order to remove the remaining slag (excess metal). This slag was pretty 
sharp and was causing issues with the stent balloons, as well as causing the stents to break in 
some places. The passivation method involves soaking the stents in a solution of water and citric 
acid, and eventually the particles will break off.  
The passivation method is very simple. We placed the stents into two different groups, 
one as a control and one as a test group. First, I weighed all of the stents and wrote down 
identifying characteristics of all of them. Then, I soaked them in a solution of bleach and water, 
and tried to brush away some of the metal particles. Next, I placed the control group in a beaker 
filled with distilled water. Then, I combined another beaker of distilled water with citric 
acid—proportion was 10% citric acid compared to the weight of the water. I placed both beakers 
on a hot plate, set at 150 degrees Celsius, for thirty minutes. At the end of the thirty minutes, I 
took them off the hot plate, rinsed all the stents again with distilled water, and weighed them 
again. The following data shows the mass of each stent, before and after passivation. The results 
of Experiment 1 were stents that had already been laser-welded together, forming a cylindrical 
shape, but had already been deployed and possessed some damages. The stents were divided into 
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the control group and the test group. Experiment 2 tested stents that had not been welded yet, so 
the steel was in a flat sheet. Experiment 3 stents were also from the first group (oxygen-laser cut), 
but they had not yet been deployed.  
 Stent # Mass Before Mass After Percent Change 
Control Group 15 0.7131g 0.7116g 0.21% 
 14 0.7190g 0.7172g 0.25% 
 4 0.7205g 0.7191g 0.19% 
 6 0.7177g 0.7157g 0.28% 
     
Test Group 16 0.7165g 0.6873g 4.08% 
 1 0.7163 0.6904g 3.62% 
 10 0.7195g 0.6956g 3.32% 














Stent # Mass Before Mass After Percent Change 
1 0.6763g 0.6566g 2.91% 
2 0.8000g 0.7665g 4.19% 
3 0.7074g 0.7041g 0.47% 
4 0.7654g 0.7333g 4.19% 
5 0.7437g 0.7228g 2.81% 
6 0.7392g 0.7150g 2.08% 
7 0.7150g 0.7077g 1.02% 
8 0.7102g 0.7089g 0.18% 
9 0.8575g 0.8461g 1.33% 
10 0.7602g 0.7442g 2.10% 
11 0.7022g 0.7021g 0.01% 
12 0.7280g 0.7205g 1.03% 
13 0.8299g 0.8176g 1.48% 
14 0.7123g 0.7095g 0.90% 
15 0.7916g 0.7485g 5.44% 
 
 
Stent # Mass Before Mass After Percent Change 
3 0.7148g 0.6889g 3.62% 
5 0.7185g 0.6946g 3.33% 
11 0.7209g 0.6948g 3.62% 
12 0.7189g 0.7084g 1.96% 
13 0.7174g 0.6946g 3.18% 
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This data shows that there was a decrease in mass among all stents in Experiment 1. It 
was a small difference with this group, since it was the control group, but water still had a small 
effect. The test group, using the citric acid passivation technique, had a large impact on the 
decrease in mass. With Experiment 2, there was a discrepancy in the temperature. The 
temperature was set to 150 degrees Fahrenheit because that was the temperature given in the 
original instructions I found. However, I completed the passivation process again with the same 
stents at a temperature of 150 degrees Celsius. As seen in the results, there was not a huge change 
in mass of these stents. But, the nitrogen laser-cutter was more successful for this round of stents, 
so there was not much metal to dissolve anyway. Experiment 3 was performed using the original 
batch of stents, so there was more slag than Experiment 2. I set the temperature at 150 degrees 
Celsius for Experiment 3. Experiment 3 removed more slag relative to Experiment 2. 
The next step to prepare the stents for deployment was to crimp them so they would be 
able to fit into the phantom arteries. To do this, we used the Edwards SAPIEN 3 Lifescience 
TAVR crimper. The goal was to crimp them down to a diameter of 8 millimeters, which was 
approximately 31 degrees on the machine. The secondary goal of the crimping experiment was to 
crimp the stents without any breakages, which had also been a problem in the first round. The 
following data shows the various measurements taken when crimping the stents. None of the 
















1 16.34 8.41 86 35 
2 16.07 8.75 94 35 
3 16.99 8.53 95 35 
4 15.72 8.66 95 35 
5 15.7 8.49 90 35 
6 16.53 8.44 85 35 
7 16.48 8.48 90 35 
8 15.64 8.57 95 35 
9 16.1 8.26 90 35 
10 16.79 8.57 90 35 
11 16.06 8.53 90 35 
12 16.2 8.57 90 35 
13 15.75 8.82 95 35 
14 16.12 8.9 95 35 





The next process was creating new balloons. In the previous version, balloons had been 
ordered from a medical supply company, but the company ran out of stock. It was also in the 
initial project proposal to create a machine that would form these balloons. The first step was to 
prepare the parasons that would serve as the balloon molds. They were formed using PET tubing 
with a 0.19 inch outer diameter and male Luer locks and they were connected using Loctite 401. 
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The glue on the parasons dried for approximately forty-eight hours, and then they were able to be 
blown into a balloon.  
The basic concept for the balloon-forming machine was to insert the parason into the 
mold, with a 3D printed piece made of resin connected on each side to try to reduce movement. 
The mold was connected to a heater, which was pre-heated to 180C. The parason was placed 
inside for twenty seconds, then removed, then placed back inside the mold for twenty more 
seconds. At the end of the second heating, the valve of the attached air compressor was opened 
for approximately half a second in order to “blow up” the balloon. Multiple trials were performed, 
but few balloons were actually suitable for the experiment. There were several issues and 
inconsistencies with version 1.0 of the machine. First, the pararsons were too wobbly inside the 
machine. It was hard to place the securing end pieces within the time constraints. Also, it was 
difficult to consistently time each trial perfectly because the pieces would get stuck inside the 
mold. Also, the machine was built on the floor, so it was difficult to see inside the machine. 












Even though the majority of the balloons were not fit to be used, data was still collected 
on them so as to improve the second version of the balloon-forming machine. During the initial 
testing, all of the balloons were filled completely with water and attached to the inflator. The 
inflator used in these tests was an actual inflator used in hospital stent deployments, and the 
packaging advised for the pressure to reach 12 atm. Collaborators at the University of Utah 
advised for the goal pressure for the balloons to be fully expanded to be 11 atm.  
There were some issues with this experiment as well. Some of the balloons burst before 
reaching 11atm, and some of the Luer locks were not glued properly and broke off from the 
parason in the middle of the expansion. Each balloon was assigned a letter and a number. G 
represented a good balloon, M was a mediocre balloon, and B were the bad balloons. They were 
randomly assigned a number. The bad balloons were so poorly misshapen that they were not 
expanded at all. The length before expansion was tested on all G and M balloons. For most of the 
balloons, the following measurements were also taken: diameter at the resting state, length and 
diameter when the pressure had reached 11 atm, and the length and diameter of the balloon after 
the balloon had been expanded and the pressure was released. For the balloons that burst, the 
thickness in the middle of the balloon and at each were recorded. An asterisk represents balloons 























G1 69mm 14.14mm  18.2mm   
G2* 90mm 14.45mm  18.72mm   
G3* 59mm   17mm   
G4* 69mm 11.46mm     
G5 92.5mm 10.92mm  19.30mm   
G6 83.42mm 17.15mm  18.16mm   
G7 93.47mm 14.12mm 120.56mm 17.4mm 109.5mm 15.7mm 
G8 86.23mm 13.27mm 104.96mm 16.9mm 97.42mm 16.06mm 
M1 85mm 14.52mm 102.84mm 17.4mm 94.35mm 15.64mm 
M2* 73.5mm 14.52mm     
M3 127.07mm 14.88mm 148.3mm 18.0mm 135.1mm 16.5mm 
M4 123.78mm 14.16mm 151.14mm 16.66mm 138.5mm 15.51mm 
M5 80.73mm 11.5mm 108.33mm 15.69mm 100.25mm 13.97mm 
M6 76.69mm 14.12mm 96.34mm 17.49mm 88.22mm 15.54mm 















G1     
G2* 0.17mm 0.02mm 0.62mm 0.61mm 
G3* 0.22mm 0.13mm 0.58mm 0.67mm 
G4* 0.01mm 0.09mm 0.76mm 0.47mm 
G5     
G6     
G7     
G8     
M1     
M2* 0.08mm  0.20mm 0.13mm 
M3     
M4     
M5 0.32mm 0.13mm 0.37mm 0.67mm 
M6 0.03mm 0.16mm 0.69mm 0.99mm 
M7 0.11mm 0.46mm 0.93mm 0.48mm 
B1 0.17mm 0.17mm 0.51mm 0.25mm 
B2 0.20mm 0.04mm 0.32mm 0.24mm 





The next step after testing the capabilities of these balloons was to prepare them for 
actual deployment within the phantom. First, when the balloons were deflated, they naturally 
folded into a three-fold shape. In order to combat this, the balloons were filled with water again, 
until they were in the resting state capacity, and then were wrapped with rubber bands. Once the 
water was removed, the balloons folded into a more crinkly, less rigid shape.  
VI. Phantom Deployment 
The phantoms were created from an expandable gel that has a Young’s Modulus similar 
to that of a coronary artery. Young’s Modulus is a term that defines the stiffness of a material. 
The gel used is called “Gel 0” and has a Young’s Modulus of 0.248MPa. This gel’s stiffness is 










These phantoms are produced by members of our lab group. Data is available and a 
publication is pending. This method is similar to other methods using ballistic gels (Morrow et 
al., 2016). In the experiment testing the balloons, a few balloons burst that had potentially been 
nicked by the metal in the stents. So, before the balloons were placed inside the stents, they were 
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wrapped in a piece of white copy paper, and then shimmied into the stent. Once the balloon was 
inside, the paper was removed.  
The initial proposal was to test stents in phantoms with no stenosis, and then 25%, 50%, 
and 75% stenosis. The phantoms take several days to set, so this first test only used the phantom 
with 50% stenosis. The phantoms were heated with a heat gun in order to ensure maximal 
visibility during the deployment. Each stent-balloon complex was placed inside the phantom 
artery in a certain position, so that the area between the second and third metal division was 
placed right where the side branch artery was connected. The inflator was filled completely up 
with water, and then connected to the balloon with tubing and the Luer lock. Then, deployment 
began.  
The inflator could not hold enough water to completely deploy the balloon to 11 atm, so 
the inflator had to be detached midway through deployment, around 6 atm. However, the stent did 
not seem to expand much after 6 atm, so potentially the calculations were off for creating this 
model seven times larger than normal. This deployment was repeated three additional times with 
three different stents, phantoms, and balloons. The results for deployment with 50% stenosis are 
as follows: 
● Trial 1: Stent 1, Balloon G1, Phantom 1 
○ The pressure reached 6 atm at its highest point. The Luer lock at the end of the 
balloon tubing broke off, so this balloon was not able to reach 11 atm. Also, there 
was not enough water inside the inflator to fully reach 11 atm. 
● Trial 2: Stent 2, Balloon G5, Phantom 2 
○ The balloon was filled with water to its resting state and was deployed a small 
amount before placing inside the phantom. Again, the balloon reached 6 atm, but 
the Luer lock broke off at this point. 
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● Trial 3: Stent 3, Balloon G6, Phantom 3 
○ The balloon expanded completely to 11atm, but then burst after approximately 
one second.  
● Trial 4: Stent 4, Balloon G7, Phantom 4 
○ The balloon reached 11 atm, and was able to stay deployed at this point for a 
significant amount of time.  
VII. Future Work 
There is still future work to be done on this project. In order to test all possible scenarios, 
the balloon-stent complex needs to be tested in phantoms with the different variations of stenosis, 
both 25% and 75%, along with a phantom with no stenosis. To do this, more balloons and stents 
will have to be made. The balloon-forming machine V2.0 is in current production, but it had not 
been completed by the publication of this paper. Due to the inconsistencies with version 1 
discussed earlier, there are several adjustments that need to be made to the new version. First, the 
machine needs to be placed at eye-level so that it is easier to see the parasons and move them in 
and out of the machine. Also, the machine needs a base plate with stoppers around the edges so as 
to raise the entire machine off of the work surface. The main change that needs to be made is 
creating a more efficient system to move the parason in and out of the heating unit. At this stage, 
the idea is to create a “train track” of sorts that can easily move the parason back and forth. There 
will also be 3D-printed pieces within the heating unit that will stop the parason at the correct 
point within the heating unit. We also hope to make tapered balloons, which were called for in the 
initial proposal.  
VIII. Conclusion 
Coronary artery disease is an ongoing issue that has been an increasing problem, even 
since 2016 since this project proposal was first created. Bifurcated arteries make interventions 
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difficult, but we hope that our project will contribute to lower rates of restenosis and more 
successful operations. There is still work to be done, as technology is rapidly changing and new 
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